QuickView for TPR domain binding (biogroup)

1. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
2. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
3. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

1. The structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90.
2. Structural plasticity of the N-terminal capping helix of the TPR domain of kinesin light chain.
3. A Tetrahymena Hsp90 co-chaperone promotes siRNA loading by ATP-dependent and ATP-independent mechani…
4. UNC-45B chaperone: the role of its domains in the interaction with the myosin motor domain.
5. Ligand recognition by the TPR domain of the import factor Toc64 from Arabidopsis thaliana.

There were no clinical trials for TPR domain binding